Search Results

Belgian biotech Galapagos is teaming with Blood Centers of America to help deploy its decentralized CAR-T therapy manufacturing platform closer to treatment centers across the U.S.

The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.

Pharmaceutical companies are combining antibodies with radioisotopes in a bid to more precisely deliver radiation to cancers and tumors.

Clinical Laserthermia Systems Americas, Inc., a leading provider of office-based, focal laser ablation systems for urologists, announced that Kearney Urology Center,PC, a Nebraska Professional Corporation located in Kearny, NE, has signed a Mobile Services Agreement to treat prostate cancer patients using CLS products.

Moffitt Cancer Center, a world-renowned cancer treatment and research center, and Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. and a leading nanobiotechnology company specializing in innovative cancer therapeutics, announced a strategic partnership aimed at advancing cancer treatment through clinical development and pre-clinical co-development initiatives.

World-renowned physicians and researchers from City of Hope®, one of the largest cancer research and treatment organizations in the United States, will present new data and offer expert perspectives on leading-edge cancer research and treatments in development at the 2024 ASCO Annual Meeting.

City of Hope, one of the largest cancer research and treatment organizations in the United States, announced that its subsidiary, Cancer Treatment Centers of America®, will fully transition its clinical locations to City of Hope’s brand.